These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32131570)

  • 1. Latent tuberculosis infection: recent progress and challenges in South Korea.
    Jeon D
    Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
    Noh CS; Kim HI; Choi H; Kim Y; Kim CH; Choi JH; Hyun IG; Baek MS
    Respir Med; 2019 Oct; 157():52-58. PubMed ID: 31522030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
    Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
    Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Latent Tuberculosis Infection Treatment Among Pediatric Patients in Korea: Prescription and Treatment Completion.
    Kim Y; Bae KS; Choi UY; Han SB; Kim JH
    J Korean Med Sci; 2024 Feb; 39(7):e64. PubMed ID: 38412611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
    Cui X; Gao L; Cao B
    Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.
    Woodruff R; Pratt R; Kolasa M
    MMWR Surveill Summ; 2024 Jun; 73(4):1-18. PubMed ID: 38833409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.
    Lee EH; Kang YA; Leem AY; Park MS; Kim YS; Kim SK; Chang J; Kim SY
    Sci Rep; 2017 Jul; 7(1):6473. PubMed ID: 28743918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
    Harries AD; Kumar AMV; Satyanarayana S; Takarinda KC; Timire C; Dlodlo RA
    Expert Rev Respir Med; 2020 Feb; 14(2):195-208. PubMed ID: 31760848
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges.
    Paton NI; Borand L; Benedicto J; Kyi MM; Mahmud AM; Norazmi MN; Sharma N; Chuchottaworn C; Huang YW; Kaswandani N; Le Van H; Lui GCY; Mao TE
    Int J Infect Dis; 2019 Oct; 87():21-29. PubMed ID: 31301458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress on diagnosis and treatment of latent tuberculosis infection.
    Ying C; He C; Xu K; Li Y; Zhang Y; Wu W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 51(6):691-696. PubMed ID: 36915977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection?
    Porter BW; Venkatappa TK
    Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Latent Tuberculosis Infection in Children from Developing Countries.
    Jain A; Lodha R
    Indian J Pediatr; 2019 Aug; 86(8):740-745. PubMed ID: 30741387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Latent Tuberculosis Infection.
    Haley CA
    Microbiol Spectr; 2017 Apr; 5(2):. PubMed ID: 28409555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort.
    Chiang LY; Baumann B; Romanowski K; Kumar D; Campbell JR; Djurdjev O; Morshed M; Sekirov I; Cook VJ; Levin A; Johnston JC
    Am J Kidney Dis; 2021 May; 77(5):696-703. PubMed ID: 32818551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
    Han SS; Lee SJ; Yim JJ; Song JH; Lee EH; Kang YA
    PLoS One; 2019; 14(9):e0222810. PubMed ID: 31536577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center.
    Arguello Perez E; Seo SK; Schneider WJ; Eisenstein C; Brown AE
    Clin Infect Dis; 2017 Nov; 65(12):2105-2111. PubMed ID: 29020308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.